Brain+ Information

Ayla is a UK digital health company delivering the gold standard in evidence-based dementia care. Our product, Ayla, is a Class I UKCA-certified medical device that helps care home and NHS teams deliver Cognitive Stimulation Therapy (CST), the only non-drug intervention recommended by both NICE and WHO for dementia. We work with care homes and NHS services to make structured, clinician-quality CST practical at scale: equipping staff with training, accreditation, and a digital platform that guides every session with minimal preparation time. In homes using Ayla, 100% of residents maintain or improve cognitive function, with a 233% increase in social engagement and significant improvements in mood and quality of life.